UPDATE 1-Long-acting injection a shot in the arm for GSK's HIV business By: Reuters: Company News August 15, 2018 at 04:00 AM EDT * GSK hopes to gain market share from market leader Gilead (Adds shares, details on competition, analyst comment) Read More >> Related Stocks: Gilead Sciences Gsk Plc ADR Johnson & Johnson